Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Journal of Lipid Research|January 27, 2011
Insulin sensitivity is not associated with palmitoleate availability in obese humansElisa Fabbrini, Faidon Magkos, Xiong Su, et al.The Journal of Clinical Investigation|January 3, 2015
Metabolically normal obese people are protected from adverse effects following weight gainElisa Fabbrini, Jun Yoshino, Mihoko Yoshino, et al.The Journal of Clinical Endocrinology and Metabolism|December 24, 2025
Sustained Action of Imapextide, a Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy VolunteersElisa Fabbrini, Anastasiya Koshkina, Michael Hackett, et al.Obesity (Silver Spring, Md.)|January 21, 2012
Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetesSamuel Klein, Elisa Fabbrini, Bruce W Patterson, et al.Gastroenterology|March 20, 2012
Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjectsFaidon Magkos, Xiong Su, David Bradley, et al.Biology of Reproduction|February 28, 2003
Ontogenesis of leptin receptor in rat Leydig cellsMassimiliano Caprio, Elisa Fabbrini, Giulia Ricci, et al.Circulation|November 15, 2017
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Kenneth W Mahaffey, Bruce Neal, Vlado Perkovic, et al.The Journal of Clinical Investigation|November 29, 2012
Gastric bypass and banding equally improve insulin sensitivity and β cell functionDavid Bradley, Caterina Conte, Bettina Mittendorfer, et al.Journal of Lipid Research|March 8, 2012
Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liverAngela M Hall, Kou Kou, Zhouji Chen, et al.Diabetologia|March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS ProgramDavid R Matthews, Qiang Li, Vlado Perkovic, et al.Pageof 5